Early clinical experience with a hybrid bioartificial liver

Scandinavian Journal of Gastroenterology

Volumn 30, Issue S208, 1995, Pages 111-117

  Demetriou, A A ^a   Rozga, J ^a   Podesta, L ^a   Lepage, E ^a   Morsiani, E ^a   Moscioni, A D ^a   Hoffman, A ^a   Mcgrath, M ^a   Kong, L ^a   Rosen, H ^a   Villamil, F ^a   Woolf, G ^a   Vierling, J ^a   Makowka, L ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Bioreactor; Fulminant hepatic failure; Hepatocytes; Liver

Indexed keywords

ADULT; ANIMAL; ARTICLE; ARTIFICIAL ORGAN; CHILD; CYTOLOGY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER; MALE; PLASMAPHERESIS; SWINE; ANIMAL CELL; ARTIFICIAL LIVER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; LIVER CELL; LIVER FAILURE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ADULT; ANIMAL; ARTIFICIAL ORGANS; CHILD; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER; MALE; PLASMAPHERESIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SWINE;

EID: 0028949815     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529509107771     Document Type: Article

References (48)

1. Fulminant hepatic failure and need for artificial liver support
2. Acute hepatic failure treated by cross circulation
3. Effects of serial resin heraoperfusion in fulminant hepatic failure
4. Extracorporeal pig-liver perfusion in treatment of hepatic coma due to fulminant hepatitis
5. Treatment of acute hepatic coma by ex vivo baboon and human liver perfusions
6. Earlier charcoal haemoperfusion in fulminant hepatic failure
7. Sorption-filtration therapy for chronic liver disease: in vitro testing and clinical correlation
8. Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis
9. Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane
10. Controlled trial of exchange-transfusion therapy in fulminant hepatitis
11. Total body washout and exchange. A valuable tool in acute hepatic coma and Reye's syndrome
12. Preparation and properties of gel-entrapped liver cell microsomes
13. Therapeutic plasmapheresis for liver failure after hepatectomy
14. Hepatic support with hepatocyte suspensions in a permeable membrane dialyzer
15. Performance of a new hybrid artificial liver support system using hepatocytes entrapped within a hydro-gel
16. Hybrid bioartificial liver in hepatic failure: preliminary clinical report
17. A new hybrid artificial liver using a combination of hepatocytes and biomatrix
18. Controlled trial of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure
19. Liver transplantation in the Cambridge/King's College Hospital series: the first 400 patients
20. Liver transplantation for fulminant hepatic failure
21. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells
22. Development of a hybrid bioartificial liver
23. Use of a novel bioartificial liver in a patient with acute liver insufficiency
24. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure
25. Continuous removal of middle molecules by hemofiltration in patients with acute liver failure
26. Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis
27. Cell culture on artificial capillaries: an approach to tissue growth in vitro
28. Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries
29. A prototype for a hybrid artificial liver
30. Studies on extracorporeal liver support. I: Preliminary studies using isolated rabbit liver cells
31. Hepatocyte perfusion within a centrifuge
32. The application of immobilized enzymes in an artificial liver support system
33. New method of hepatocyte transplantation and extracorporeal liver support
34. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration
35. Long-term cryopreserved human hepatocytes maintain drug metabolizing ability
36. Evaluation of a hepatocyte-entrapment hollow-fiber bioreactor: a potential bioartificial liver
37. Pharmacokinetic analysis verifies P-450 function during in vitro and in vivo application of a bioartificial liver
38. Bioartificial liver using hepatocytes on biosilon microcarriers: treatment of chemically induced acute hepatic failure in rats
39. Improved liver function following treatment with an extracorporeal liver assist device
40. Reversal of fulminant hepatic failure using an extracorporeal liver assist device
41. Improvement of the performance of a hybrid-type artificial liver utilizing isolated hepatocytes: the use of conditioned medium
42. vitro benzodiazepine metabolism of adult rat hepatocytes seeded in a hollow-fiber membrane device
43. Development of bioartificial liver: bilirubin conjugation in Gunn rats
44. Temporary organ substitution by hemoperfusion through suspension of active donor hepatocytes in a total complex of intensive therapy in patients with acute hepatic insufficiency
45. Connective tissue biomatrix: its isolation and utilization for long-term cultures of normal rat hepatocytes
46. Induction of albumin gene transcription in hepatocytes byextracellular matrix proteins
47. Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat livers by serum from patients with fulminant hepatic failure
48. Gas supply across membranes in bioreactors for hepatocyte culture